Bioactive Compounds from Marine Invertebrates
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Chemoecology for Drug Discovery".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 28
Special Issue Editor
Interests: immunity; marine invertebrates; cell biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The marine environment is an exceptional source of novel bioactive natural products, including secondary metabolites and peptides, which are primarily found in marine invertebrates such as sponges, arthropods, annelids, molluscs, echinoderms and tunicates. The unique bioactive compounds derived from these organisms possess immense biotechnological potential. The number of natural products isolated from marine organisms is rapidly increasing, with such products having a wide range of applications, including antiviral, anti-inflammatory, anti-cancer, neuroactive, nutraceutical, cosmetic, antibiotic, antifouling, biomaterial and food storage uses. Current studies in diverse research domains, including biomedicine, environmental sciences and nutrition, are focused on the identification of marine molecules exhibiting biological activities with the potential to be developed into drugs for human use.
In this Special Issue, we invite the submission of studies that address the identification of bioactive molecules derived from marine invertebrates via experimental and in silico research, and their potential application in biotechnological contexts.
Dr. Aiti Vizzini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolite
- peptide
- marine invertebrate
- marine natural products
- biotechnological application
- drugs
- metabolomic
- proteomic
- bioinformat
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
